NASDAQ : PPCB
Propanc Biopharma, Inc. — Financial statements
Healthcare · Biotechnology · Australia
Last price 1.84 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.16M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 15.28M | 15.28M | 33.76M | 1.29M | 1.53M | 1.73M |
| Research & Development | 625.48K | 625.48K | 223.72K | 248.10K | 247.92K | 256.05K |
| Other Operating Expenses | 2.28M | 2.28M | 23.30M | |||
| Operating Expenses | 18.19M | 18.19M | 57.28M | 1.54M | 1.78M | 1.99M |
| Operating Income | -18.19M | -18.19M | -57.28M | -1.54M | -1.78M | -1.99M |
| Interest Expense | -430.54K | -430.54K | -563.76K | -665.84K | -532.82K | -568.80K |
| Interest & Investment Income | 161.00 | 161.00 | 9.00 | 60.00 | 36.00 | 5.61K |
| Currency Exchange Gain (Loss) | 32.15K | 32.15K | -89.24K | 22.08K | 5.88K | -42.40K |
| Other Non Operating Income (Expenses) | -91.99K | -91.99K | -121.15K | 175.53K | -530.33K | -99.11K |
| EBT Excluding Unusual Items | -18.68M | -18.68M | -58.05M | -2.00M | -2.83M | -2.70M |
| Legal Settlements | -150.00K | -150.00K | ||||
| Other Unusual Items | -36.93K | -36.93K | -871.03K | 54.56K | 43.47K | -17.50K |
| Pretax Income | -18.86M | -18.86M | -58.92M | -1.95M | -2.79M | -2.71M |
| Income Tax Expense | -129.13K | -129.84K | -54.98K | |||
| Net Income | -18.86M | -18.86M | -58.92M | -1.82M | -2.66M | -2.66M |
| Preferred Dividends & Other Adjustments | 932.25K | 932.25K | 192.96K | 466.27K | 700.34K | |
| Net Income to Common | -19.79M | -19.79M | -58.92M | -2.01M | -3.13M | -3.36M |
| Shares Outstanding (Basic) | 112.37K | 112.37K | 15.87K | |||
| Shares Outstanding (Diluted) | 112.37K | 112.37K | 15.87K | |||
| EPS (Basic) | -176.16 | -176.16 | -3,712.17 | |||
| EPS (Diluted) | -176.16 | -176.16 | -3,712.17 | |||
| Free Cash Flow | -5.69M | -5.69M | -405.17K | -935.12K | -1.11M | -1.44M |
| Free Cash Flow Per Share | -50.61 | -50.61 | -25.53 | |||
| EBITDA | -18.18M | -18.18M | -57.28M | -1.54M | -1.77M | -1.99M |
| D&A For EBITDA | 997.00 | 997.00 | 297.00 | 297.00 | 1.67K | 1.99K |
| EBIT | -18.19M | -18.19M | -57.28M | -1.54M | -1.78M | -1.99M |
Balance sheet
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 832.01K | 832.01K | 12.09K | 21.09K | 10.05K | 4.07K |
| Cash & Short-Term Investments | 832.01K | 832.01K | 12.09K | 21.09K | 10.05K | 4.07K |
| Other Receivables | 13.69K | 13.69K | 5.30K | 2.95K | 2.87K | 2.34K |
| Receivables | 13.69K | 13.69K | 5.30K | 2.95K | 2.87K | 2.34K |
| Prepaid Expenses | 7.66M | 7.66M | 8.33M | 6.12K | 8.62K | |
| Other Current Assets | 34.92K | 34.92K | 1.38K | 1.41K | ||
| Total Current Assets | 8.54M | 8.54M | 8.35M | 25.44K | 19.04K | 15.03K |
| Property, Plant & Equipment | 44.70K | 44.70K | 59.41K | 17.80K | 39.29K | 64.55K |
| Long-Term Deferred Charges | 291.77K | 27.12K | ||||
| Other Long-Term Assets | 4.19M | 4.19M | 10.93M | 2.01K | 2.00K | 2.08K |
| Total Assets | 12.78M | 12.78M | 19.63M | 72.36K | 60.33K | 81.65K |
| Accounts Payable | 1.13M | 1.13M | 1.25M | 1.21M | 966.72K | 943.02K |
| Accrued Expenses | 1.74M | 1.74M | 2.35M | 1.53M | 1.21M | 939.74K |
| Short-Term Debt | 460.81K | 460.81K | 1.56M | 870.27K | 505.13K | 977.61K |
| Current Portion of Leases | 24.49K | 24.49K | 17.66K | 19.36K | 21.50K | 20.61K |
| Other Current Liabilities | 403.89K | 163.65K | 452.84K | 182.01K | ||
| Total Current Liabilities | 3.35M | 3.35M | 5.58M | 3.79M | 3.16M | 3.06M |
| Long-Term Debt | 105.63K | 58.64K | ||||
| Long-Term Leases | 23.82K | 23.82K | 41.75K | 19.28K | 42.32K | |
| Total Liabilities | 3.38M | 3.38M | 5.73M | 3.85M | 3.18M | 3.11M |
| Common Stock | 3.31K | 3.31K | 464.00 | 8.00 | 7.65K | 240.00 |
| Additional Paid-In Capital | 152.75M | 152.75M | 138.25M | 61.70M | 60.31M | 57.36M |
| Retained Earnings | -144.48M | -144.48M | -125.62M | -66.70M | -64.68M | -61.56M |
| Treasury Stock | -46.48K | -46.48K | -46.48K | -46.48K | -46.48K | -46.48K |
| Comprehensive Income & Other | 1.18M | 1.18M | 1.32M | 1.27M | 1.29M | 1.21M |
| Total Common Equity | 9.40M | 9.40M | 13.91M | -3.78M | -3.12M | -3.03M |
| Shareholders' Equity | 9.40M | 9.40M | 13.91M | -3.78M | -3.12M | -3.02M |
| Total Liabilities & Equity | 12.78M | 12.78M | 19.63M | 72.36K | 60.33K | 81.65K |
| Total Debt | 509.12K | 509.12K | 1.73M | 948.27K | 545.92K | 1.04M |
| Net Cash (Debt) | 322.89K | 322.89K | -1.71M | -927.19K | -535.87K | -1.04M |
| Net Cash Per Share | 2.87 | 2.87 | -108.03 | |||
| Filing Date Shares Outstanding | 633.11K | 633.11K | 51.23K | |||
| Total Common Shares Outstanding | 331.08K | 331.08K | 46.45K | |||
| Working Capital | 5.19M | 5.19M | 2.77M | -3.77M | -3.14M | -3.05M |
| Book Value Per Share | 28.40 | 28.40 | 299.40 | |||
| Tangible Book Value | 9.40M | 9.40M | 13.91M | -3.78M | -3.12M | -3.03M |
| Tangible Book Value Per Share | 28.40 | 28.40 | 299.40 | |||
| Machinery | 31.31K | 31.31K | 25.08K | 25.43K | 28.62K |
Cash flow statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -18.86M | -18.86M | -58.92M | -1.82M | -2.66M | -2.66M |
| Depreciation & Amortization | 22.70K | 22.70K | 20.19K | 21.66K | 22.93K | 5.67K |
| Other Amortization | 210.08K | 210.08K | 303.56K | 294.00K | 202.95K | 47.97K |
| Stock-Based Compensation | 13.57M | 13.57M | 55.97M | 141.36K | 387.14K | |
| Other Operating Activities | -35.01K | -35.01K | 1.09M | 152.33K | 715.49K | 613.57K |
| Change in Accounts Payable | -183.01K | -183.01K | 187.73K | 242.41K | 80.97K | 18.87K |
| Change in Other Net Operating Assets | -401.93K | -401.93K | 950.48K | 175.01K | 391.61K | 148.56K |
| Operating Cash Flow | -5.68M | -5.68M | -405.17K | -935.12K | -1.11M | -1.44M |
| Capital Expenditures | -4.93K | -4.93K | ||||
| Investing Cash Flow | -4.93K | -4.93K | ||||
| Short-Term Debt Issued | 175.00K | 175.00K | 542.50K | 836.86K | 590.25K | 766.50K |
| Long-Term Debt Issued | 78.25K | 78.25K | 343.70K | 224.88K | ||
| Total Debt Issued | 253.25K | 253.25K | 886.20K | 1.06M | 590.25K | 766.50K |
| Short-Term Debt Repaid | -875.13K | -875.13K | -130.79K | -142.91K | ||
| Long-Term Debt Repaid | -185.38K | -185.38K | ||||
| Total Debt Repaid | -1.06M | -1.06M | -130.79K | -142.91K | ||
| Net Debt Issued (Repaid) | -807.26K | -807.26K | 755.41K | 918.84K | 590.25K | 766.50K |
| Issuance of Common Stock | 6.31M | 6.31M | 23.06K | 523.47K | 724.29K | |
| Other Financing Activities | -264.66K | |||||
| Financing Cash Flow | 6.46M | 6.46M | 490.76K | 941.89K | 1.11M | 1.49M |
| Foreign Exchange Rate Adjustments | 50.19K | 50.19K | -94.58K | 4.26K | -2.49K | -52.67K |
| Net Cash Flow | 819.92K | 819.92K | -9.00K | 11.04K | 5.98K | 1.81K |
| Free Cash Flow | -5.69M | -5.69M | -405.17K | -935.12K | -1.11M | -1.44M |
| Free Cash Flow Per Share | -50.61 | -50.61 | -25.53 | |||
| Levered Free Cash Flow | 1.66M | 1.66M | 12.90M | -784.32K | -507.38K | -1.50M |
| Unlevered Free Cash Flow | 1.72M | 1.72M | 12.95M | -662.18K | -377.32K | -1.19M |
| Cash Interest Paid | 131.69K | 131.69K | 30.71K | 9.49K | 2.88K | 2.39K |
| Change in Working Capital | -584.94K | -584.94K | 1.14M | 417.42K | 472.59K | 167.44K |
Ratios
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.09M | 3.42M | 48.19M | 411.68K | ||
| Enterprise Value | 766.06K | 4.55M | 49.39M | 1.34M | ||
| Last Close Price | 1.72 | 15.00 | 1,037.50 | 18,712.57 | 2,020,958.00 | 36,750,000.00 |
| PB Ratio | 0.06 | 0.36 | 3.46 | -0.11 | ||
| P/TBV Ratio | 0.12 | 0.36 | 3.46 | |||
| Debt / Equity Ratio | 0.05 | 0.05 | 0.12 | -0.25 | -0.17 | -0.34 |
| Net Debt / Equity Ratio | -0.03 | -0.03 | 0.12 | -0.24 | -0.17 | -0.34 |
| Net Debt / EBITDA Ratio | 0.02 | 0.02 | -0.03 | -0.60 | -0.30 | -0.52 |
| Net Debt / FCF Ratio | 0.06 | 0.06 | -4.23 | -0.99 | -0.48 | -0.72 |
| Quick Ratio | 0.25 | 0.25 | 0.00 | 0.01 | 0.00 | 0.00 |
| Current Ratio | 2.55 | 2.55 | 1.50 | 0.01 | 0.01 | 0.01 |
| Return on Equity (ROE) | -161.86% | -161.86% | -1,163.67% | |||
| Return on Assets (ROA) | -70.14% | -70.14% | -363.36% | -1,447.01% | -1,564.19% | -2,626.42% |
| Return on Capital Employed (ROCE) | -192.90% | -192.90% | -407.60% | 41.30% | 57.30% | 66.80% |
| Earnings Yield | -10,241.70% | -551.94% | -122.28% | -442.22% | ||
| FCF Yield | -522.30% | -166.42% | -0.84% | -227.15% | ||
| Buyback Yield / Dilution | -607.94% | -607.94% |